MiniVax Overview
- Year Founded
-
2010

- Status
-
Out of Business
- Latest Deal Type
-
Liquidation
MiniVax General Information
Description
Developer of novel vaccines and therapeutics for the treatment and prevention of opportunistic infections. The company helps in decreasing the burden of opportunistic fungal infections on the healthcare system and improve outcomes for affected patients.
Contact Information
Website
www.minivaxcorp.comCorporate Office
- 1441 Canal Street
- Suite 314
- New Orleans, LA 70112
- United States
Corporate Office
- 1441 Canal Street
- Suite 314
- New Orleans, LA 70112
- United States
MiniVax Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Bankruptcy: Liquidation | 31-Dec-2015 | Completed | Bankruptcy: Liquidation | |||
4. Accelerator/Incubator | 03-Dec-2013 | Completed | Startup | |||
3. Angel (individual) | 02-May-2013 | Completed | Startup | |||
2. Grant | 30-Aug-2011 | $600K | Completed | Startup | ||
1. Grant | 01-May-2011 | Completed | Startup |
MiniVax FAQs
-
When was MiniVax founded?
MiniVax was founded in 2010.
-
Where is MiniVax headquartered?
MiniVax is headquartered in New Orleans, LA.
-
What industry is MiniVax in?
MiniVax’s primary industry is Pharmaceuticals.
-
Is MiniVax a private or public company?
MiniVax is a Private company.
-
What is MiniVax’s current revenue?
The current revenue for MiniVax is
. -
How much funding has MiniVax raised over time?
MiniVax has raised $130K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »